Literature DB >> 880971

Effect of beta-adrenergic blockade on blood pressure variation in patients with moderate hypertension.

D L Clement, M G Bogaert, R Pannier.   

Abstract

The effect of beta-adrenergic blockade on blood pressure variation was studied in ten patients with moderate hypertension. Supine systolic and diastolic blood pressures were measured every 5 min during six hours sessions, using an ultrasonic method. Systolic and diastolic variation in each six hour session was defined as the standard deviation of the mean of systolic and diastolic readings made in that period. After 3 weeks of single-blind placebo, a 12 week double-blind randomized crossover study was initiated with placebo (6 weeks) and atenolol (100 mg b.i.d. for 3 weeks and 200 mg b.i.d. for 3 weeks). Systolic and diastolic blood pressure and heart rate decreased significantly (p less than 0.01) during atenolol treatment. Diastolic variation did not change significantly, whereas systolic variation decreased slightly but significantly (p less than 0.05) when expressed in absolute values, but not when expressed as a percentage of systolic blood pressure. It is concluded that beta-adrenergic blockade decreases blood pressure and heart rate without causing significant changes in spontaneous systolic or diastolic variation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 880971     DOI: 10.1007/bf00566528

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Clinical experience with use of ultrasound sphygmomanometer.

Authors:  C F George; P J Lewis; A Petrie
Journal:  Br Heart J       Date:  1975-08

2.  Hyperkinetic heart in severe hypertension: a separate clinical hemodynamic entity.

Authors:  M M Ibrahim; R C Tarazi; H P Dustan; E L Bravo; R W Gifford
Journal:  Am J Cardiol       Date:  1975-05       Impact factor: 2.778

3.  VARIATION IN ARTERIAL PRESSURE THROUGHOUT THE DAY AND NIGHT.

Authors:  D W RICHARDSON; A J HONOUR; G W FENTON; F H STOTT; G W PICKERING
Journal:  Clin Sci       Date:  1964-06       Impact factor: 6.124

4.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.

Authors:  R C Tarazi; H P Dustan
Journal:  Am J Cardiol       Date:  1972-05       Impact factor: 2.778

5.  Effects of propranolol on the pressor response to noxious stimuli in hypertensive patients.

Authors:  J A Nicotero; V Beamer; S E Moutsos; A P Shapiro
Journal:  Am J Cardiol       Date:  1968-11       Impact factor: 2.778

6.  Atenolol and bendrofluazide in hypertension.

Authors:  J C Petrie; D B Galloway; J Webster; W T Simpson; J A Lewis
Journal:  Br Med J       Date:  1975-10-18

7.  Accuracy of an automated ultrasound blood pressure monitor.

Authors:  H M Hochberg; H Salomon
Journal:  Curr Ther Res Clin Exp       Date:  1971-02

8.  Controlled study of atenolol in treatment of hypertension.

Authors:  L Hansson; H Aberg; B E Karlberg; A Westerlund
Journal:  Br Med J       Date:  1975-05-17

9.  Effect of intravenous propranolol on the systemic circulatory response to sustained handgrip.

Authors:  H R MacDonald; R P Sapru; S H Taylor; K W Donald
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

10.  A comparison of the actions of ICI66082 and propranolol on cardiac and peripheral beta-adrenoceptors.

Authors:  B N Singh; H E Nisbet; E A Harris; R M Whitlock
Journal:  Eur J Pharmacol       Date:  1975-11       Impact factor: 4.432

View more
  6 in total

Review 1.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

2.  Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.

Authors:  H J Waal-Manning; P Bolli
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335

Review 3.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

4.  Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.

Authors:  A G Dupont; P Vanderniepen; A M Bossuyt; M H Jonckheer; R O Six
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

Review 5.  Does anxiety or cardiovascular reactivity have a causal role in hypertension?

Authors:  R H Rosenman
Journal:  Integr Physiol Behav Sci       Date:  1991 Oct-Dec

6.  Beta-adrenergic blockade in stress protection. Limited effect of metoprolol in psychological stress reaction.

Authors:  E Heidbreder; G Pagel; A Röckel; A Heidland
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.